Pharmaceutical industry export delivery value (half year)

STO-REC-STATEVF2RBT1 Official
30.9 billionUSD

China · as of 30 Jun 2026

Pharmaceutical industry export delivery value in China (half year) stood at 30.9 billion USD as of 30 June 2026 (State Council).

Original source
Publisher
State Council
Authority tier
T1 Official
Locator
Value of China's innovative drug out-licensing deals hit new high in H1
Retrieved
17 Sep 2026
Status
Verified

What the source says

The industry's export delivery value exceeded 210 billion yuan (about 30.91 billion U.S. dollars) in the first six months, up 9 percent from a year earlier.

Verbatim extraction verified: The figure 30.9 billion USD is directly attested in the quoted passage (Value of China's innovative drug out-licensing deals hit new high in H1).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Other sources disagree

2 records report a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.

ValueDivergenceSource organisationDocumentLocatorDetails
210 billion CNY+579.4%State CouncilValue of China's innovative drug out-licensing deals hit new high in H1Value of China's innovative drug out-licensing deals hit new high in H1Open record
210 billion CNY+579.4%MOFCOM上半年我国创新药对外技术授权交易额创新高上半年我国创新药对外技术授权交易额创新高Open record

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_EVF2RBA5V3YFSQBWJTCC7AVM9Y
MLA
State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026, https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_EVF2RBA5V3YFSQBWJTCC7AVM9Y.
Chicago
State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026. https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_EVF2RBA5V3YFSQBWJTCC7AVM9Y.
BibTeX
@misc{statecouncil2026pharmaceutical7avm9y, author = {{State Council of China}}, title = {Value of China's innovative drug out-licensing deals hit new high in H1}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_EVF2RBA5V3YFSQBWJTCC7AVM9Y}, note = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STATEVF2RB T1 Official

Primary Source

Publisher
State Council of China · homepage ↗
Authority tier
Tier 1 · Multilateral Official
Report
Value of China's innovative drug out-licensing deals hit new high in H1
Type
Press release
Published
Locator
Value of China's innovative drug out-licensing deals hit new high in H1
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_EVF2RBA5V3YFSQBWJTCC7AVM9Y